Home / TRADICHEM INDUSTRIAL SERVICES

TRADICHEM INDUSTRIAL SERVICES

EU GMP-Certified Pharmaceutical Manufacturing Site At TIS PHARMA, we develop API compaction and granulation processes for third parties to improve production efficiency through our patented technology, Hipering.

Spain Europe

TRADICHEM INDUSTRIAL SERVICES

EU GMP-Certified Pharmaceutical Manufacturing Site At TIS PHARMA, we develop API compaction and granulation processes for third parties to improve production efficiency through our patented...

TRADICHEM INDUSTRIAL SERVICES
TRADICHEM INDUSTRIAL SERVICES
TRADICHEM INDUSTRIAL SERVICES
TRADICHEM INDUSTRIAL SERVICES
TRADICHEM INDUSTRIAL SERVICES
TRADICHEM INDUSTRIAL SERVICES
TRADICHEM INDUSTRIAL SERVICES

About the plant

EU GMP-Certified Pharmaceutical Manufacturing Site

At TIS PHARMA, we develop API compaction and granulation processes for third parties to improve production efficiency up to 60% and the consequent impact on the reduction of industrial costs through our patented technology, Hipering.

After the synthesis or fermentation processes to obtain APIs, many of these active pharmaceutical ingredients require compaction and granulation stages so they can be adjusted to the manufacture of the different final galenic forms. Additionally, many of the APIs need to be pre-compacted when they arrive at drug factories with equipment not specifically designed for this process, with the consequent cost in materials, loss of performance, long lead times and other costs derived from this pre-compaction.
At TIS Pharma, we provide a pharmaceutical service for the physical transformation of raw materials, keeping purity intact, which translates into an increase of up to 60% in operational efficiency for manufacturers of final pharmaceutical forms and the consequent impact on the reduction of industrial costs.

Likewise, our GMP industrial platform allows the control and standardization of batches of raw materials according to the industrial needs of each client; either at the level of the manufacturer of the active ingredient, as well as that of the final pharmaceutical form.


Certifications
  • ISO
  • EMA (EU GMP)
  • FDA (cGMP)
  • World Health Organization (GMP / HACCP)

Activity
  • API PROCESSING manufacturing

Features
  • Uses: Commercial (Phase IV), Human, Veterinary
  • Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
  • DEA: N/A
  • BSL: 1, 2
  • Therapeutic areas: N/A
  • Markets: FDA (USA), EMA (EU)

Batch Size / Reactor
  • Small, Medium, Large

Services
  • Development services, Manufacturing services, Preformulation studies, R&D, Formulation / Galenic design, QbD (Quality by Design), Process development, Process optimization, Pilot plant, Formulation mixing, Research batches, Scale-up, Pilot batches, Batch records

Contact us

If you have any questions or suggestions, click here. We will be happy to assist you.

Want to see all the information?

Unleash the full power of MAI CDMO

Register for free

Sylentis
Pharmaron
Lannett
Grifols
ADRAGOS PHARMA
Liof Pharma